Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double‐blind, placebo‐controlled investigations on the effects of a novel estrogen–progestogen combination (Climodien®, Lafamme®) versus estrogen alone
Open Access
- 27 August 2003
- journal article
- clinical trial
- Published by Wiley in Journal of Sleep Research
- Vol. 12 (3), 239-254
- https://doi.org/10.1046/j.1365-2869.2003.00356.x
Abstract
Differences in sleep and awakening quality between 51 insomniac postmenopausal syndrome patients and normal controls were evaluated. In a subsequent double‐blind, placebo‐controlled, comparative, randomized, three‐arm trial (Climodien 2/3 = estradiol valerate 2 mg + the progestogen dienogest 3 mg = regimen A, estradiol valerate 2 mg = regimen EV, and placebo = regimen P), the effects of 2 months of hormone replacement therapy were investigated, followed by a 2‐month open‐label phase in which all patients received Climodien® 2/2 (EV 2 mg + dienogest 2 mg = regimen A*). Polysomnography at baseline demonstrated significantly deteriorated sleep initiation and maintenance, increased S1 and decreased S2 in patients. Subjective sleep and awakening quality, well‐being, morning drive, wakefulness, memory and reaction time performance were deteriorated too. Treatment with both regimen A and regimen EV induced a moderate, although nonsignificant, improvement in the primary efficacy variable wakefulness during the total sleep period compared with baseline, while under placebo no changes occurred. Secondary efficacy variables concerning sleep initiation and maintenance, and sleep architecture showed similar findings. The apnea and apnea–hypopnea indices improved significantly under regimen A, compared with both baseline and placebo. Subjective sleep and awakening quality improved significantly after regimen A and EV compared with baseline, with the drug‐induced changes being superior to those induced by placebo. In the open‐label phase, subjective sleep quality improved further, significantly in the former regimen A group. Awakening quality, somatic complaints and morning thymopsyche did not yield any significant findings. Concerning morning noopsychic performance, memory improved significantly after regimen A compared with baseline, fine motor activity after regimen EV. Reaction time performance increased with all three compounds. In conclusion, Climodien significantly improved subjective sleep quality, the apnea and apnea–hypopnea indices of insomniac postmenopausal syndrome patients, while it only marginally improved variables concerning objective sleep and awakening quality.Keywords
This publication has 55 references indexed in Scilit:
- Sleep Laboratory Studies in Restless Legs Syndrome Patients as Compared with Normals and Acute Effects of RopiniroleNeuropsychobiology, 2000
- Sleep Laboratory Studies in Restless Legs Syndrome Patients as Compared with Normals and Acute Effects of RopiniroleNeuropsychobiology, 2000
- Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal womenFertility and Sterility, 1999
- Reproductive Hormones, Aging, and SleepSeminars in Reproductive Medicine, 1999
- When does estrogen replacement therapy improve sleep quality?American Journal of Obstetrics and Gynecology, 1998
- Soporific Effect of the Neurosteroid Pregnanolone in Relation to the Substance’s Plasma Level: A Pilot StudyNeuropsychobiology, 1996
- Insomnia in Generalized Anxiety Disorder: Polysomnographic, Psychometric and Clinical Investigations before, during and after Therapy with a Long- versus a Short-Half-Life Benzodiazepine (Quazepam versus Triazolam)Neuropsychobiology, 1994
- Neurosteroid pregnenolone induces sleep-EEG changes in man compatible with inverse agonistic GABAA-receptor modulationBrain Research, 1993
- Psychiatric morbidity and the menopause; screening of general population sample.BMJ, 1975
- THE INFLUENCE OF AGE AND TEMPERAMENT ON THE ADULT HUMAN SLEEP—WAKEFULNESS PATTERNBritish Journal of Psychology, 1969